歌剧等 发表于 2025-3-25 07:01:10

http://reply.papertrans.cn/23/2264/226395/226395_21.png

HUMP 发表于 2025-3-25 09:36:06

http://reply.papertrans.cn/23/2264/226395/226395_22.png

medieval 发表于 2025-3-25 14:26:43

http://reply.papertrans.cn/23/2264/226395/226395_23.png

Infirm 发表于 2025-3-25 17:02:26

http://reply.papertrans.cn/23/2264/226395/226395_24.png

immunity 发表于 2025-3-25 22:01:57

Cytostatic Therapy of Chronic Myelogenous Leukemia: Review and Perspectives, 20, 28, 35, 41]. CML has remained uniformly fatal, and the only curative therapy available up to now has been bone marrow transplantation . This, however, can be offered only to the small proportion of CML patients of sufficiently young age who have an HLA-compatible donor.

Feckless 发表于 2025-3-26 01:24:39

http://reply.papertrans.cn/23/2264/226395/226395_26.png

就职 发表于 2025-3-26 05:34:45

http://reply.papertrans.cn/23/2264/226395/226395_27.png

limber 发表于 2025-3-26 10:56:43

,Konzeption und Beschreibung der Geräte, CML a specific chromosome abnormality, the Philadelphia chromosome (Ph.) (22q-) is present in 90%–95% of patients . The Ph. chromosome results, in most instances, from a balanced reciprocal translocation between chromosome 9 and 22 .

可互换 发表于 2025-3-26 14:56:46

Erhard Tietel,Roland Kunkel-van Kaldenkerkenh.-positive cells as assessed by cytogenetic and c-abl/bcr analysis. Thirteen patients failed to show sustained antileukemic response to IFN-gamma. These data demonstrate that the use of IFN-gamma is not effective in inducing hematologic remissions in patients with stable-phase CML in the treatment schedule.

烧瓶 发表于 2025-3-26 19:58:08

http://reply.papertrans.cn/23/2264/226395/226395_30.png
页: 1 2 [3] 4 5 6
查看完整版本: Titlebook: Chronic Myelocytic Leukemia and Interferon; Pathophysiological, Dieter Huhn,Klaus Peter Hellriegel,Norbert Niederl Conference proceedings